| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +3.06K | 100% | $7.93 | +$24.3K |
| Sells | 0 | ||||
| Net | +2 | +3.06K | 100% | +$24.3K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Estate of Joseph Feldschuh | 10%+ Owner | $24.9M | 18 Sep 2023 | ||
| Michael Feldschuh | Chief Executive Officer, Director | $1.68M | +$16.3K | +0.98% | 04 Apr 2025 |
| Jonathan Feldschuh | Chief Scientific Officer, Director | $350K | 06 Dec 2024 | ||
| Robert Michel | Chief Financial Officer | $235K | +$8K | +3.53% | 10 Mar 2025 |
| John Jefferies | Chief Medical Officer | $214K | 12 Nov 2025 | ||
| Edward Feuer | Director | 24 Jun 2025 | |||
| Henry Cremisi | Director | 24 Jun 2025 | |||
| Joy Goudie | Director | 24 Jun 2025 | |||
| Caleb DesRosiers | Director | 24 Jun 2025 | |||
| JAMES LOMBARD | Director | 11 Jul 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|